Autotransfusion Devices Market Size, Share, Growth Analysis and Forecasts to 2027 | Braile Biomedica, Fresenius SE, Haemonetics, LivaNova, Redax, Teleflex

Organ transplantation is a surgical procedure that is done in case a patient's organ stops functioning entirely. Although, the organ transplantation is generally done for organs such as the heart, liver, and kidney, the rising cases of chronic diseases are leading to the need for transplantation for the other organs such as lung, pancreases, cornea, and vascular tissues. Organ transplantation is considered one of the advanced in the modern medical industry. These types of procedures generally take hours, and there is more loss of blood. Thus the autotransfusion is one of the useful methods to prevent blood loss with the help of autotransfusion devices as required. According to the National Chronic Kidney Disease fact sheet, in 2017, around 30 million people have chronic kidney diseases in the US. Furthermore, according to the National Institute of Diabetes and Digestive and Kidney Diseases, about 661,000 Americans have kidney failure, out of which 468,000 patients are undergoing dialysis, and 193,000 have undergone kidney transplantation. Owing to these facts, the cases of kidney transplantations are likely to increase in the coming years. Thus, the rising need for organ transplantation is among the key factors driving the transplant diagnostics market.

Get sample PDF copy @ http://bit.ly/3cfrH20

The autotransfusion devices market is expected to reach US$ 1,283.52 Mn in 2027 from US$ 936.64 Mn in 2019. The market is estimated to grow with a CAGR of 4.1% from 2020-2027.

The report provides trends prevailing in the global autotransfusion devices market and the factors driving the market along with those that act as hindrances. Factors such as involvement of rare blood groups, rising number of transplant procedures and rising prevalence of chronic diseases are estimated to propel the market growth during the forecast period. However, risks associated with autotransfusion is expected to restraint the growth of the market.

The autotransfusion devices market majorly consists of the players such as BD, Braile Biomedica, Fresenius SE & Co. KGaA, Haemonetics Corporation, LivaNova PLC, Medtronic, Redax S.p.A., SARSTEDT AG and Co. KG , Teleflex Incorporated and Zimmer Biomet among others. Company such as BD is focusing on inorganic strategies such as acquisition which has resulted in the expansion of its product portfolio and market growth.

The global autotransfusion devices market, based on the type, is segmented into product, and accessories. The accessories segment led the autotransfusion devices market by type in 2019, and; it is expected to retain its dominance during the forecast period. Based on application, the market is divided into cardiac surgeries, orthopedic surgeries, organ transplantation, trauma procedures, and others. And on the basis of end user the market is classified as hospitals, specialty clinics, and ambulatory surgery centers.

Application Insights

The autotransfusion devices market on the basis of application is segmented into cardiac surgeries, orthopedic surgeries, organ transplantation, trauma procedures, and others. In 2019, the cardiac surgeries segment accounted for the largest market share in the global autotransfusion devices market by application. The cardiac surgeries segment is also expected to dominate the largest market share in the global market scenarios owing to the significantly rising incidences of cardiovascular diseases across the world.

End User Insights

The autotransfusion devices market on the basis of end user is segmented into hospitals, specialty clinics, and ambulatory surgical centers. In 2019, the hospital segment register for the largest market share in the global autotransfusion devices market by end user. The hospital segment is also expected to dominate the largest market share owing to the services and facilities offered to the patients.

Strategic Insights

Some of the activities undertaken by the companies, which have promoted its growth are, majorly inorganic developments. Company such as BD among others have implemented inorganic strategy in the autotransfusion device market. The strategy has assisted in bringing various changes in the autotransfusion devices market. The company have utilized strategy such as acquisition, which has enabled BD to expand its business and product portfolio in the coming future.

Purchase copy of Autotransfusion Devices Market research reports @ http://bit.ly/2uDB62G

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Semiconductors, Healthcare, Manufacturing, Automotive and Defense.

Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com

This release was published on openPR.